ChemicalBook >> CAS DataBase List >>GSK 2033

GSK 2033

CAS No.
1221277-90-2
Chemical Name:
GSK 2033
Synonyms
SK2033;GSK 2033;LXR antagonist 2033;GSK2033 >=98% (HPLC);Liver X receptor,Inhibitor,GSK 2033,inhibit,LXR,GSK2033,GSK-2033;2,4,6-Trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]benzenesulfonamide;2,4,6-trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]-benzenesulfonamide;Benzenesulfonamide, 2,4,6-trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]-
CBNumber:
CB93146298
Molecular Formula:
C29H28F3NO5S2
Molecular Weight:
591.66
MDL Number:
MFCD28396416
MOL File:
1221277-90-2.mol
MSDS File:
SDS
Last updated:2024-11-19 20:33:22

GSK 2033 Properties

storage temp. 2-8°C
solubility DMF:5.0(Max Conc. mg/mL);8.45(Max Conc. mM)
DMSO:17.46(Max Conc. mg/mL);29.51(Max Conc. mM)
form powder
color white to beige

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338

GSK 2033 price More Price(16)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML1617 GSK2033 ≥98% (HPLC) 1221277-90-2 5MG $159 2023-06-20 Buy
Sigma-Aldrich SML1617 GSK2033 ≥98% (HPLC) 1221277-90-2 25MG $639 2023-06-20 Buy
Cayman Chemical 25443 GSK2033 ≥98% 1221277-90-2 1mg $32 2024-03-01 Buy
Cayman Chemical 25443 GSK2033 ≥98% 1221277-90-2 5mg $139 2024-03-01 Buy
Cayman Chemical 25443 GSK2033 ≥98% 1221277-90-2 10mg $230 2024-03-01 Buy
Product number Packaging Price Buy
SML1617 5MG $159 Buy
SML1617 25MG $639 Buy
25443 1mg $32 Buy
25443 5mg $139 Buy
25443 10mg $230 Buy

GSK 2033 Chemical Properties,Uses,Production

Uses

GSK 2033 is a potent LXR antagonist.

Biochem/physiol Actions

GSK2033 is an antagonist of the nuclear receptor liver-X-receptor (LXR) with pIC50 values of 7.0 for LXRα and 7.4 for LXRβ. Treatment of murine CD41 T cells with GSK2033 enhanced cellular proliferation and Th1/Th2/Th17 differentiation. In another study, the conjugated linoleic acid (CLA)-induced expression of efflux protein ATP-binding-cassette transporter A1 (ABCA1) was completely abolished by preincubation with GSK2033, showing that CLA mediated regulation of ABCA-1 expression is LXR dependent.

storage

Store at +4°C

GSK 2033 Preparation Products And Raw materials

Raw materials

Preparation Products

GSK 2033 Suppliers

Global( 52)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32957 60
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 32165 58
Chemia Biotechnology(Shanghai) Co., Ltd
+8613816753574 info@chemia-pharm.com CHINA 311 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6391 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581 sales@chemhifuture.com China 3135 58
Jilin Chinese Academy of Sciences-yanshen Technology
+undefined18143011203 info@chemextension.com China 42056 58
Aladdin Scientific
+1-+1(833)-552-7181 sales@aladdinsci.com United States 57505 58
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185 18149758185 sales-cpd@caerulumpharma.com China 3466 58
Sichuan Wei Keqi Biological Technology Co., Ltd. 028-81700200 18116577057 3003855609@qq.com China 7887 56
Sigma-Aldrich 021-61415566 800-8193336 orderCN@merckgroup.com China 51456 80

View Lastest Price from GSK 2033 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
GSK2033 pictures 2024-11-19 GSK2033
1221277-90-2
US $44.00-163.00 / mg 99.05% 10g TargetMol Chemicals Inc.
  • GSK2033 pictures
  • GSK2033
    1221277-90-2
  • US $44.00-163.00 / mg
  • 99.05%
  • TargetMol Chemicals Inc.
GSK 2033 LXR antagonist 2033 2,4,6-Trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]benzenesulfonamide Benzenesulfonamide, 2,4,6-trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]- GSK2033 >=98% (HPLC) Liver X receptor,Inhibitor,GSK 2033,inhibit,LXR,GSK2033,GSK-2033 2,4,6-trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]-benzenesulfonamide SK2033 1221277-90-2 C29H28F3NO5S2